Short and long-term impact of intravitreal anti-VEGF therapy interruption in retinal vein occlusion during the COVID-19 pandemic: functional outcomes and AI-based fluid analysis of macular edema
The results of our study suggest that delaying IVI for RVO patients during the COVID-19 lockdown resulted in a temporary decline in BCVA and a recurrence of ME. However, these effects were not sustained long term, as both BCVA and ME control returned to baseline levels by 6 months, with no significant changes observed at the two-year follow-up.
Authors
- Andrea Montesel (ORCID: https://orcid.org/0000-0002-1910-9976)
- Chiara Maria Eandi (ORCID: https://orcid.org/0000-0003-3656-1689)
- Jennifer Cattaneo (ORCID: https://orcid.org/0000-0002-3750-2886)
- Emmanuelle Moret (ORCID: https://orcid.org/0000-0002-7540-6991)
- Adham Elwakil (ORCID: https://orcid.org/0009-0009-4881-6643)
- Mattia Tommasoni
Institutions
- Fondation Asile des Aveugles (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- International Journal of Retina and Vitreous
- Published
- 2025-08-05
- DOI
- https://doi.org/10.1186/s40942-025-00717-x
- Citations
- 1
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- Université de Lausanne